Antioxidative Capacity ELISA

$425.00
Catalog
30-5200
The Antioxidative Capacity ELISA is a colorimetric test system for the determination of antioxidative capacity in Serum and EDTA-Plasma. Research Use Only. Not for Use in Diagnostic Procedures.
The human body is constantly under attack from free radicals that occur as part of normal cell metabolism, and by exposure to environmental factors such as UV light, cigarette smoke, environmental pollutants and gamma radiation. The resulting Reactive Oxygen Species (ROS) circulate freely in the body with access to all organs and tissues, which can have serious repercussions throughout the body. The body possesses a number of mechanisms both to control the production of ROS and to cope with free radicals in order to limit or repair the damage to tissues. Overproduction of ROS or insufficient defence mechanisms lead to a dangerous disbalance in the organism. Thereby several pathomechanisms implicated in over 100 human diseases, e.g. cardiovascular disease, cancer, diabetes mellitus, inflammatory disease, aging, etc., were induced. Determination of the antioxidative capacity becomes of fundamental importance in medical diagnosis and in research. The ImAnOx®-Assay is fast, reliable and easy to perform. The total antioxidative capacity is measured.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in USA Only
Range
130 - 393 µmol/L
Sensitivity
130 µmol/L
Sizes
Other
Size Other
50 Tests
Sample Types
Plasma, Serum
Inc Time Minute
15
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
20
Detection
Colorimetric

Antioxidative Capacity ELISA

30-5200

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

An End to Subjective RPR Reading?
An End to Subjective RPR Reading? Development of a Novel Automated Nontreponemal Immunoassay for Syphilis
Discover ALPCO’s novel automated nontreponemal immunoassay for syphilis testing. Reduce subjectivity, improve workflow efficiency, and support faster treatment decisions.
View Now
Variation In Calprotectin Results by Methodology
Same Sample, Different Result? What New Research Reveals About Fecal Calprotectin Variability
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
View Now
ALPCO News
NuvinkaDx Announces Major Milestones for Portfolio Companies GeneProof and ALPCO
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.